Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
    1.
    发明授权
    Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis 有权
    可用于调节血管发生的色氨酰-tRNA合成酶衍生的多肽

    公开(公告)号:US07476651B2

    公开(公告)日:2009-01-13

    申请号:US11903030

    申请日:2007-09-20

    Abstract: The invention provides a method for inhibiting ocular neovascularization in a patient. The method comprises administering to a patient an ocular neovascularization inhibiting amount of a water-soluble polypeptide selected from the group consisting of SEQ ID NO: 12, SEQ ID NO: 7, and an ocular neovascularization inhibiting fragment thereof, which includes at least one of amino acid residue signature sequences HVGH (SEQ ID NO:10) and KMSAS (SEQ ID NO:11). A method for assaying the angiogenesis inhibiting activity of a composition is also provided.

    Abstract translation: 本发明提供一种抑制患者眼新生血管形成的方法。 该方法包括向患者施用眼新生血管形成抑制量的选自SEQ ID NO:12,SEQ ID NO:7的水溶性多肽和其新生血管形成抑制片段,其包括至少一种 氨基酸残基特征序列HVGH(SEQ ID NO:10)和KMSAS(SEQ ID NO:11)。 还提供了用于测定组合物的血管发生抑制活性的方法。

    Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis
    6.
    发明授权
    Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis 有权
    用于调节血管生成的人氨基-tRNA合成酶多肽

    公开(公告)号:US08101566B2

    公开(公告)日:2012-01-24

    申请号:US12655717

    申请日:2010-01-06

    CPC classification number: C12N9/93 A61K38/00

    Abstract: A method of suppressing angiogenesis in a mammal (e.g., for treating tumors, tumor metastasis or a condition that would benefit from decreased angiogenesis) comprises the step of administering to the mammal an angiostatically effective amount of a pharmaceutical composition comprising an isolated antiangiogenic truncated tryptophanyl-tRNA synthetase (TrpRS) polypeptide or an isolated nucleic acid that comprises a polynucleotide sequence that encodes the truncated TrpRS polypeptide. The truncated TrpRS polypeptide comprises residues 71-471 of SEQ ID NO: 10, residues 48-471 of SEQ ID NO: 10, or a polypeptide of approximately 47 kD molecular weight produced by cleavage of the polypeptide of SEQ ID NO: 10 with polymorphonuclear leucocyte elastase.

    Abstract translation: 抑制哺乳动物血管发生的方法(例如,用于治疗肿瘤,肿瘤转移或有益于血管生成减少的病症)包括向哺乳动物施用血管生成有效量的药物组合物的步骤,其包含分离的抗血管生成截短的色氨酸 - tRNA合成酶(TrpRS)多肽或分离的核酸,其包含编码截短的TrpRS多肽的多核苷酸序列。 截短的TrpRS多肽包含SEQ ID NO:10的残基71-471,SEQ ID NO:10的残基48-471或通过用多核型切割SEQ ID NO:10的多肽产生的约47kD分子量的多肽 白细胞弹性蛋白酶。

    Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis
    9.
    发明申请
    Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis 有权
    可用于调节血管发生的色氨酰-tRNA合成酶衍生的多肽

    公开(公告)号:US20070218527A1

    公开(公告)日:2007-09-20

    申请号:US11803326

    申请日:2007-05-14

    Abstract: The invention provides an isolated nucleic acid encoding a water-soluble polypeptide fragment of human tryptophanyl-tRNA synthetase, which is useful for the inhibition of angiogenesis. The nucleic acid comprises a polynucleotide of SEQ ID NO: 6, a polynucleotide hybridizable to SEQ ID NO: 6, a polynucleotide that encodes the polypeptide of SEQ ID NO: 7, a polynucleotide that encodes a polypeptide of SEQ ID NO: 12, a polynucleotide that encodes a polypeptide epitope of SEQ ID NO: 7, or a polynucleotide that is hybridizable to a polynucleotide that encodes a polypeptide epitope of SEQ ID NO: 7. Vectors and recombinant cells comprising the nucleic acid are also provided.

    Abstract translation: 本发明提供编码人色氨酰-tRNA合成酶的水溶性多肽片段的分离的核酸,其可用于抑制血管发生。 核酸包含SEQ ID NO:6的多核苷酸,可与SEQ ID NO:6杂交的多核苷酸,编码SEQ ID NO:7的多肽的多核苷酸,编码SEQ ID NO:12的多肽的多核苷酸, 编码SEQ ID NO:7的多肽表位的多核苷酸或可与编码SEQ ID NO:7的多肽表位的多核苷酸杂交的多核苷酸。还提供了载体和包含该核酸的重组细胞。

Patent Agency Ranking